Description

Emily Ellis is the founder of FintastIQ, a growth and value creation consultancy helping PE-backed portfolio companies and scaled B2B businesses expand revenue and margin through pricing, packaging, and go-to-market execution. Over 20 years, she has led monetization and commercial excellence programs with boards and executive teams, including pricing architecture, discount governance, sales effectiveness, and operating model improvements. She previously served as an Associate Partner at McKinsey (Growth, Marketing & Sales) and Head of Pricing at BCG Gamma. Emily is also a bootstrapped SaaS founder with a successful exit.

Languages

English
Native or bilingual

Workplace preferences

Can work on-site

Chicago (up to 50km)

FINTASTIQ
Founder
July 2024 - Today (1 year and 11 months)
Chicago, IL, USA
Advisor to industrial, healthcare, and SaaS portfolio companies on pricing, marketing, and sales strategy through end-to-end commercial programs (diagnostic through pilot and execution), delivering double-digit revenue and EBITDA improvements Partner to private equity firms to accelerate post-acquisition value creation through pricing, packaging, and sales effectiveness Specialist in primary market research, including Voice of Customer (VoC) analysis, pricing and packaging research, and willingness-to-pay studies, to inform pricing design, refine value propositions, and uncover growth opportunities Recent pricing engagements:
• o Rebuilt pricing engine for a global healthcare and life sciences distributor with customer segmentation, margin guardrails, automated deal reviews, and pricing analytics dashboards, delivering an estimated $120M EBITDA impact
• o Executed a post-acquisition pricing transformation for a global personal protective equipment manufacturer, refining price-setting and deal desk practices to capture $80M in EBITDA impact
• o Implemented a holistic commercial excellence program for a pharmacy benefits optimizer, driving impact through pricing redesign, price increases, contract T&Cs, bundling, and product enhancements for $94M in EBITDA gains
Pricing strategy Sales Excellence Growth hacking
MCKINSEY & COMPANY
Associate Partner, Growth, Marketing, and Sales
April 2022 - June 2024 (2 years and 2 months)
Chicago, IL, USA
Leader in the healthcare and life sciences pricing practice, driving innovative pricing strategies for pharmaceuticals, medtech, and healthcare services, resulting in revenue improvements of 10-15% for clients Designed a new value-based pricing model for a global pharmaceutical client, aligning product pricing with patient outcomes and securing favorable payor contracts Advised healthcare providers on renegotiating managed care contracts and value-based care reimbursement strategies, leveraging data-driven insights to improve provider financial performance while maintaining patient access Directed a comprehensive pricing diagnostic for a medtech company, identifying pricing improvement, up-sell, and cross-sell opportunities across lines of business, and implemented new tiered discount guardrails that increased profitability by 20%
KPMG
Director,Pricing Strategy andCommercialExcellence
May 2021 - April 2022 (11 months)
Chicago, IL, USA
Led commercial excellence programs that expanded margins by 8 - 15% through pricing and other commercial levers Led a pricing transformation for a pharma software client, developing subscription-based models and data-driven discount frameworks that increased recurring revenue by 25% and enhanced customer retention rates Led a contract excellence program for a global chemicals manufacturer, redesigning standard T&Cs to improve margin capture, reduce leakage, and strengthen customer alignment Advised a leading dental distributor on optimizing pricing and sales strategies, boosting margins up to 18%